Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?

Mean analyst price target for Acurx Pharmaceuticals (ACXP) implies a 226.3% upside. The metric has limited proven effectiveness, but strong analyst agreement in raising earnings estimates suggests a potentially positive — though speculative — upside for the stock.

Analysis

Mean analyst price target for Acurx Pharmaceuticals (ACXP) implies a 226.3% upside. The metric has limited proven effectiveness, but strong analyst agreement in raising earnings estimates suggests a potentially positive — though speculative — upside for the stock.